Literature DB >> 20549547

Potential tumor suppressive function of miR-196b in B-cell lineage acute lymphoblastic leukemia.

Suman Bhatia1, Deepak Kaul, Neelam Varma.   

Abstract

Keeping in view the fact that genes coding microRNAs (miRNAs) have been found to be localized in chromosomal regions susceptible to genetic translocations, this study was addressed to identify and characterize the miRNAs that are present near/within the regions involved in genetic translocations characteristic of B-cell acute lymphoblastic leukemia (B-cell ALL). Out of six such identified miRNAs miR-196b was not only found to be significantly down-regulated in both EB-3 cell line as well as B-cell ALL patients as compared to that found in the corresponding controls, but also had the inherent capacity to down-regulate the highly expressed c-myc gene, a consequence of genetic translocation characteristic of EB-3 cells at both transcriptional and translational level. This phenomenon was in conformity with the observed reciprocal relationship between the expressed genes coding for miR-196b and c-myc in B-cells derived from ALL patients as well as c-myc gene was found to be a putative target of miR-196b as predicted by bioinformatic algorithms. Also down-regulation of c-myc gene was accompanied by decreased expressions of c-myc effector genes coding for hTERT, Bcl-2, and AATF. Based upon these results, we propose for the first time that miR-196b has the inherent capacity to down-regulate the overamplified c-myc gene recognized as a common pathognomonic feature leading to cancer in general and B-cell ALL in particular. Hence miR-196b can be assigned with the tumor suppressor function and can be of therapeutic importance in paving the way toward the treatment of B-cell ALL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20549547     DOI: 10.1007/s11010-010-0406-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  36 in total

1.  Up-regulation of telomerase in human B lymphocytes occurs independently of cellular proliferation and with expression of the telomerase catalytic subunit.

Authors:  B T Hu; R A Insel
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

2.  High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma.

Authors:  Markus Metzler; Monika Wilda; Kerstin Busch; Susanne Viehmann; Arndt Borkhardt
Journal:  Genes Chromosomes Cancer       Date:  2004-02       Impact factor: 5.006

Review 3.  A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.

Authors:  O A Kent; J T Mendell
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

4.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

Review 5.  Molecular biology of Burkitt's lymphoma.

Authors:  J L Hecht; J C Aster
Journal:  J Clin Oncol       Date:  2000-11-01       Impact factor: 44.544

6.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

7.  Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis.

Authors:  J Wang; X Liu; W Jiang; L Liang
Journal:  Chin Med J (Engl)       Date:  2000-11       Impact factor: 2.628

8.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

9.  Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.

Authors:  Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

Review 10.  MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death.

Authors:  R Schickel; B Boyerinas; S-M Park; M E Peter
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

View more
  32 in total

1.  Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia.

Authors:  Suman Bhatia; Deepak Kaul; Neelam Varma
Journal:  Mol Cell Biochem       Date:  2010-10-06       Impact factor: 3.396

2.  MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma.

Authors:  Chenggang Wang; Ren Ren; Haolin Hu; Changjun Tan; Miao Han; Xiaolin Wang; Yun Zheng
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

3.  Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.

Authors:  Javeed Iqbal; Yulei Shen; Xin Huang; Yanyan Liu; Laura Wake; Cuiling Liu; Karen Deffenbacher; Cynthia M Lachel; Chao Wang; Joseph Rohr; Shuangping Guo; Lynette M Smith; George Wright; Sharathkumar Bhagavathi; Karen Dybkaer; Kai Fu; Timothy C Greiner; Julie M Vose; Elaine Jaffe; Lisa Rimsza; Andreas Rosenwald; German Ott; Jan Delabie; Elias Campo; Rita M Braziel; James R Cook; Raymond R Tubbs; James O Armitage; Dennis D Weisenburger; Louis M Staudt; Randy D Gascoyne; Timothy W McKeithan; Wing C Chan
Journal:  Blood       Date:  2014-12-10       Impact factor: 22.113

4.  MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.

Authors:  D-J Min; T Ezponda; M K Kim; C M Will; E Martinez-Garcia; R Popovic; V Basrur; K S Elenitoba-Johnson; J D Licht
Journal:  Leukemia       Date:  2012-09-13       Impact factor: 11.528

5.  MicroRNA expression is deregulated by aberrant methylation in B-cell acute lymphoblastic leukemia mouse model.

Authors:  Wei Xia; Limei Liu; Yidan Wang; Yihan Wang; Hetong Hui; Xinyuan Fan; Tianqi Wang
Journal:  Mol Biol Rep       Date:  2022-01-10       Impact factor: 2.316

Review 6.  Targeted therapy in gastric cancer: personalizing cancer treatment based on patient genome.

Authors:  Sun Min Lim; Jae Yun Lim; Jae Yong Cho
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

7.  The microRNA miR-196b acts as a tumor suppressor in Cdx2-driven acute myeloid leukemia.

Authors:  Vijay P S Rawat; Maria Götze; Avinash Rasalkar; Naidu M Vegi; Susann Ihme; Silvia Thoene; Alessandro Pastore; Deepak Bararia; Hartmut Döhner; Konstanze Döhner; Michaela Feuring-Buske; Leticia Quintanilla-Fend; Christian Buske
Journal:  Haematologica       Date:  2019-09-26       Impact factor: 9.941

8.  MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3θ.

Authors:  Kara A Scheibner; Brianne Teaboldt; Mary Claire Hauer; Xiaochun Chen; Srujana Cherukuri; Yin Guo; Shannon M Kelley; Zhenqiu Liu; Maria R Baer; Shelly Heimfeld; Curt I Civin
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

9.  miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.

Authors:  Zejuan Li; Hao Huang; Ping Chen; Miao He; Yuanyuan Li; Stephen Arnovitz; Xi Jiang; Chunjiang He; Elizabeth Hyjek; Jun Zhang; Zhiyu Zhang; Abdel Elkahloun; Donglin Cao; Chen Shen; Mark Wunderlich; Yungui Wang; Mary Beth Neilly; Jie Jin; Minjie Wei; Jun Lu; Peter J M Valk; Ruud Delwel; Bob Lowenberg; Michelle M Le Beau; James Vardiman; James C Mulloy; Nancy J Zeleznik-Le; Paul P Liu; Jiwang Zhang; Jianjun Chen
Journal:  Nat Commun       Date:  2012-02-21       Impact factor: 14.919

10.  Transcriptional regulation of miR-196b by ETS2 in gastric cancer cells.

Authors:  Yu-Lun Liao; Ling-Yueh Hu; Kuo-Wang Tsai; Chew-Wun Wu; Wen-Ching Chan; Sung-Chou Li; Chun-Hung Lai; Meng-Ru Ho; Wen-Liang Fang; Kuo-Hung Huang; Wen-Chang Lin
Journal:  Carcinogenesis       Date:  2012-01-31       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.